GlassScriptPhysician profile
Bradley Schaeffer
NPI 1952701195
$13,052.83
in general payments reported to CMS, 2019-2025
19 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,616 · 2020: $211 · 2021: $337 · 2022: $152 · 2023: $10K · 2024: $315 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,850 · Travel and Lodging: $1,297 · Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,850.00 |
| Travel and Lodging | $1,297.11 |
| Food and Beverage | $589.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $8,850.00 | 2023 | Exparel, Zilretta, Iovera |
| Treace Medical Concepts, INC. | $1,612.84 | 2021-2023 | |
| Medical Device Business Services, INC. | $1,182.05 | 2019 | |
| Stryker Corporation | $377.07 | 2019-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Easyfuse |
| Gilead Sciences, INC. | $343.84 | 2024-2025 | Biktarvy |
| Horizon Therapeutics Plc | $268.94 | 2019-2020 | |
| Wright Medical Technology, INC. | $124.03 | 2019 | |
| Paragon 28, INC. | $48.13 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $45.47 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $38.37 | 2019 | |
| Smith+Nephew, INC. | $37.35 | 2019 | |
| Glaxosmithkline, LLC. | $29.23 | 2023 | Trelegy Ellipta, Shingrix |
| Organogenesis INC. | $15.92 | 2021 | |
| Bioventus LLC | $15.32 | 2024 | Exogen Ultrasound Bone Healing System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.46 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $14.38 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $12.98 | 2021 | |
| Tactile Systems Technology INC | $12.69 | 2020 | |
| Royal Biologics, INC. | $9.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.